Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prognostic biomarkers in melanoma: a 2023 update from clinical trials in different therapeutic scenarios.

Expert review of molecular diagnostics - 1 May 2024

Roccuzzo Gabriele, Sarda Cristina, Pala Valentina, Ribero Simone, Quaglino Pietro

Abstract excerpt

INTRODUCTION: Over the past decade, significant advancements in the field of melanoma have included the introduction of a new staging system and the development of immunotherapy and targeted therapies, leading to changes in substage classification and impacting patient prognosis. Despite these strides, early detection remains paramount. The quest for dependable prognostic biomarkers is ongoing, given melanoma's...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Clinical Trials as Topic

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Immunotherapy

Share to Melanoma

Share to Molecular Targeted Therapy

Share to Mutation

Share to Prognosis

Share to Tumor Microenvironment

Source

Identifiers

PMID: 38738539
DOI: 10.1080/14737159.2024.2347484

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prognostic biomarkers in melanoma: a 2023 update from clinical trials in different therapeutic scenarios.PMID 38738539Read ↗

Prognostic and predictive biomarkers in melanoma: an updateSemantic proximity Read ↗

Biomarker-Driven Personalization of Neoadjuvant Immunotherapy in MelanomaSemantic proximity Read ↗

Unraveling the Wide Spectrum of Melanoma BiomarkersSemantic proximity Read ↗

Companion diagnostics and predictive biomarkers for PD-1/PD-L1 immune checkpoint inhibitors therapy in malignant melanoma.Semantic proximity Read ↗

Recent Progress in Mutation-driven Therapy, Immunotherapy and Combination Therapy for the Treatment of Melanoma.Semantic proximity Read ↗

Bioinformatic and Machine Learning Applications in Melanoma Risk Assessment and Prognosis: A Literature Review.Semantic proximity Read ↗

Molecular stratification of metastatic melanoma using gene expression profiling: Prediction of survival outcome and benefit from molecular targeted therapy.Semantic proximity Read ↗

The Impact of TMB on Immunotherapy Protocols: A Comprehensive Analysis of Four Major CancersSemantic proximity Read ↗

Evaluating Tumour Mutational Burden as a Key Biomarker in Personalized Cancer Immunotherapy: A Pan-Cancer ApproachSemantic proximity Read ↗

Recognition, Staging, and Management of Melanoma.Semantic proximity Read ↗

Melanoma subtypes: genomic profiles, prognostic molecular markers and therapeutic possibilitiesSemantic proximity Read ↗

Melanoma: Prognostic Factors and Factors Predictive of Response to Therapy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.